You are here: Industry Insights > acquisition

News List

Ferring acquires Rebiotix Inc. biospectrumasia
April 08, 2018
The most advanced investigational microbiome treatment from Rebiotix is RBX2660, a non-antibiotic treatment currently in Phase 3 development for the prevention of recurrent CDI
Agilent Tech to acquire Lasergen for $105M biospectrumasia
April 04, 2018
Lasergen and Agilent have been collaborating on building a next-generation sequencing workflow for clinical applications.
Fujifilm to acquire 2 biotech units for $800M biospectrumasia
April 02, 2018
Fujifilm plans to acquire all outstanding shares of Irvine Scientific (ISUS) and IS Japan (ISJ).
CRH Medical Corporation Announces the Purchase of Shreveport Sedation Associates biospace
March 20, 2018
CRH Medical Corporation announces that it has completed an accretive transaction whereby CRH has acquired a gastroenterology ("GI") anesthesia practice (100%) in Shreveport, Louisiana ("Shreveport").
Agilent Technologies to acquire Advanced Analytical Tech biospectrumasia
March 08, 2018
This acquisition will enhance Agilent’s existing expertise and technology, while giving customers a more comprehensive set of solutions.
Celgene Scoops Up San Diego Biotech in $7B Deal biospace
January 09, 2018
Celgene began the week of the J.P. Morgan Healthcare Conference with a $7 billion announcement. The company said it will acquire San Diego-based Impact Biomedicines and its JAK inhibitor progra
Nuvo Pharmaceuticals acquires global product rights to Resultz® pharmaasia
January 05, 2018
Nuvo Pharmaceuticals Inc.has announced its acquisition of the global, ex-U.S.rights to Resultz® from Piedmont Pharmaceuticals LLC.
Thermo Fisher acquires Phenom World biospectrumasia
January 02, 2018
The addition of Phenom World's leading desktop SEM platform strengthens Thermo Fisher's leadership in electron microscopy.
Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal biospace
December 28, 2017
Mallinckrodt, based in Staines-Upon-Thames, UK, is acquiring Rockville, Maryland-based Sucampo Pharmaceuticals for $1.2 billion.
Roche boosts oncology portfolio with $1.7bn acquisition pharmafile
December 25, 2017
Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for $1.7 billion.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page